PV-1019

CAS No. ——

PV-1019( NSC-744039 | NSC744039 | PV1019 )

Catalog No. M16921 CAS No. ——

A potent, ATP-competitive and highly selective Chk2 inhibitor with IC50 of 138 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    PV-1019
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, ATP-competitive and highly selective Chk2 inhibitor with IC50 of 138 nM.
  • Description
    A potent, ATP-competitive and highly selective Chk2 inhibitor with IC50 of 138 nM; displays much reduced or no activity against a panel of 52 other cellular kinases, including Chk1; inhibits Chk2-mediated phosphorylation of Cdc25C (IC50=260 nM), and nd HDMX degradation in response to DNA damage; protects normal mouse thymocytes against ionizing radiation-induced apoptosis.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    NSC-744039 | NSC744039 | PV1019
  • Pathway
    Angiogenesis
  • Target
    Chk
  • Recptor
    Chk
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    ——
  • Formula Weight
    379.38
  • Molecular Formula
    C18H17N7O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    7-nitro-1H-indole-2-carboxylic acid {4-[1-(guanidinohydrazone)-ethyl]-phenyl}-amide

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jobson AG, et al. J Pharmacol Exp Ther. 2009 Dec; 331(3):816-26.
molnova catalog
related products
  • CCT241533

    A potent and selective ATP-competitive inhibitor of CHK2 K5777:N5777with IC50 of 3 nM.

  • GDC0575 monohydrochl...

    GDC-0575 is a potent and selective inhibitor of cell cycle checkpoint kinase 1 (Chk1) with an IC50 of 1.2?nM. GDC-0575 specifically binds to and inhibits Chk1; this may result in tumor cells bypassing Chk1-dependent cell cycle arrest in the S and G2/M phases, which permits the cells to undergo DNA repair prior to entry into mitosis.

  • LY2603618

    A potent and selective small molecule inhibitor of Chk1 (IC50=?7 nM); promotes impaired DNA synthesis and elevates H2A.X phosphorylation indicative of DNA damage and premature entry into mitosis.